182 related articles for article (PubMed ID: 31708418)
41. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.
Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R
Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells.
Alimova I; Birks DK; Harris PS; Knipstein JA; Venkataraman S; Marquez VE; Foreman NK; Vibhakar R
Neuro Oncol; 2013 Feb; 15(2):149-60. PubMed ID: 23190500
[TBL] [Abstract][Full Text] [Related]
43. Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.
Byers HM; Adam MP; LaCroix A; Leary SE; Cole B; Dobyns WB; Mefford HC
Am J Med Genet A; 2017 Jan; 173(1):245-249. PubMed ID: 27734605
[TBL] [Abstract][Full Text] [Related]
44. Atypical Teratoid/Rhabdoid Tumor: Revisiting Histomorphology and Immunohistochemistry With Analysis of Cyclin D1 Overexpression and
Sali AP; Epari S; Nagaraj TS; Sahay A; Chinnaswamy G; Shetty P; Moiyadi A; Gupta T
Int J Surg Pathol; 2021 Apr; 29(2):155-164. PubMed ID: 32703045
[No Abstract] [Full Text] [Related]
45. Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults.
Thomas C; Wefers A; Bens S; Nemes K; Agaimy A; Oyen F; Vogelgesang S; Rodriguez FJ; Brett FM; McLendon R; Bodi I; Burel-Vandenbos F; Keyvani K; Tippelt S; Poulsen FR; Lipp ES; Giannini C; Reifenberger G; Kuchelmeister K; Pietsch T; Kordes U; Siebert R; Frühwald MC; Johann PD; Sill M; Kool M; von Deimling A; Paulus W; Hasselblatt M
Acta Neuropathol; 2020 Feb; 139(2):277-286. PubMed ID: 31732806
[TBL] [Abstract][Full Text] [Related]
46. A Molecular Take on Malignant Rhabdoid Tumors.
Tang M; Verhaak RGW
Trends Cancer; 2016 May; 2(5):217-218. PubMed ID: 28741508
[TBL] [Abstract][Full Text] [Related]
47. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
48. Primary atypical teratoid/rhabdoid tumor of the clival region. Case report.
Kazan S; Göksu E; Mihci E; Gökhan G; Keser I; Gürer I
J Neurosurg; 2007 Apr; 106(4 Suppl):308-11. PubMed ID: 17465367
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors.
Deisch J; Raisanen J; Rakheja D
Pediatr Dev Pathol; 2011; 14(5):353-9. PubMed ID: 21417895
[TBL] [Abstract][Full Text] [Related]
50. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors.
Theruvath J; Sotillo E; Mount CW; Graef CM; Delaidelli A; Heitzeneder S; Labanieh L; Dhingra S; Leruste A; Majzner RG; Xu P; Mueller S; Yecies DW; Finetti MA; Williamson D; Johann PD; Kool M; Pfister S; Hasselblatt M; Frühwald MC; Delattre O; Surdez D; Bourdeaut F; Puget S; Zaidi S; Mitra SS; Cheshier S; Sorensen PH; Monje M; Mackall CL
Nat Med; 2020 May; 26(5):712-719. PubMed ID: 32341579
[TBL] [Abstract][Full Text] [Related]
51. A Diagnostic Pitfall: Atypical Teratoid Rhabdoid Tumor Versus Dedifferentiated/Poorly Differentiated Chordoma: Analysis of a Mono-institutional Series.
Buccoliero AM; Caporalini C; Scagnet M; Baroni G; Moscardi S; Mussa F; Giordano F; Sardi I; Genitori L
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):147-154. PubMed ID: 28777153
[TBL] [Abstract][Full Text] [Related]
52. Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.
Lobón-Iglesias MJ; Andrianteranagna M; Han ZY; Chauvin C; Masliah-Planchon J; Manriquez V; Tauziede-Espariat A; Turczynski S; Bouarich-Bourimi R; Frah M; Dufour C; Blauwblomme T; Cardoen L; Pierron G; Maillot L; Guillemot D; Reynaud S; Bourneix C; Pouponnot C; Surdez D; Bohec M; Baulande S; Delattre O; Piaggio E; Ayrault O; Waterfall JJ; Servant N; Beccaria K; Dangouloff-Ros V; Bourdeaut F
Nat Commun; 2023 Oct; 14(1):6669. PubMed ID: 37863903
[TBL] [Abstract][Full Text] [Related]
53. Concurrent myeloid sarcoma, atypical teratoid/rhabdoid tumor, and hypereosinophilia in an infant with a germline SMARCB1 mutation.
Metts JL; Park SI; Soares BP; Fong C; Biegel JA; Goldsmith KC
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28111898
[TBL] [Abstract][Full Text] [Related]
54. Atypical teratoid/rhabdoid tumor (ATRT) arising from the 3rd cranial nerve in infants: a clinical-radiological entity?
Oh CC; Orr BA; Bernardi B; Garré ML; Rossi A; Figà-Talamanca L; Robinson GW; Patay Z
J Neurooncol; 2015 Sep; 124(2):175-83. PubMed ID: 26148473
[TBL] [Abstract][Full Text] [Related]
55. Atypical teratoid/rhabdoid tumor of the central nervous system in an 18-year-old patient.
Samaras V; Stamatelli A; Samaras E; Stergiou I; Konstantopoulou P; Varsos V; Judkins AR; Biegel JA; Barbatis C
Clin Neuropathol; 2009; 28(1):1-10. PubMed ID: 19216214
[TBL] [Abstract][Full Text] [Related]
56. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
[TBL] [Abstract][Full Text] [Related]
57. Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis.
Kotch C; Fisher MJ; Lin F; Zhong Y; Gallo D; Fan Z; Chen J; Santi M; Li MM
Cancer Genet; 2022 Apr; 262-263():1-4. PubMed ID: 34972035
[TBL] [Abstract][Full Text] [Related]
58. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
59. [Gemcitabine and Docetaxel for the Treatment of Relapsed and Refractory Malignant Rhabdoid Tumor of Kidney and Atypical Teratoid Rhabdoid Tumor].
Matsubara K; Yamasaki K; Tanimura K; Hira K; Okuhiro Y; Ishii Y; Nitani C; Okada K; Fujisaki H; Hara J
Gan To Kagaku Ryoho; 2021 Apr; 48(4):537-540. PubMed ID: 33976041
[TBL] [Abstract][Full Text] [Related]
60. Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases.
Broggi G; Gianno F; Shemy DT; Massimino M; Milanaccio C; Mastronuzzi A; Rossi S; Arcella A; Giangaspero F; Antonelli M
J Neurooncol; 2022 Mar; 157(1):1-14. PubMed ID: 35217948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
